Literature DB >> 8921986

The roles of telomeres and telomerase in cell life span.

C M Counter1.   

Abstract

Telomeres cap and protect the ends of chromosomes from degradation and illegitimate recombination. The termini of a linear template cannot, however, be completely replicated by conventional DNA-dependent DNA polymerases, and thus in the absence of a mechanisms to counter this effect, telomeres of eukaryotic cells shorten every round of DNA replication. In humans and possibly other higher eukaryotes, telomere shortening may have been adopted to limit the life span of somatic cells. Human somatic cells have a finite proliferative capacity and enter a viable growth arrested state called senescence. Life span appears to be governed by cell division, not time. The regular loss of telomeric DNA could therefore serve as a mitotic clock in the senescence programme, counting cell divisions. In most eukaryotic organisms, however, telomere shortening can be countered by the de novo addition of telomeric repeats by the enzyme telomerase. Cells which are "immortal' such as the human germ line or tumour cell lines, established mouse cells, yeast and ciliates, all maintain a stable telomere length through the action of telomerase. Abolition of telomerase activity in such cells nevertheless results in telomere shortening, a process that eventually destabilizes the ends of chromosomes, leading to genomic instability and cell growth arrest or death. Therefore, loss of terminal DNA sequences may limit cell life span by two mechanisms: by acting as a mitotic clock and by denuding chromosomes of protective telomeric DNA necessary for cell viability.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921986     DOI: 10.1016/s0165-1110(96)90006-8

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  31 in total

Review 1.  Complex regulation of telomerase activity: implications for cancer therapy.

Authors:  K S Elenitoba-Johnson
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 2.  Pluripotent stem cells: origin, maintenance and induction.

Authors:  Maria P De Miguel; Sherezade Fuentes-Julián; Yago Alcaina
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

3.  Binding linkage in a telomere DNA-protein complex at the ends of Oxytricha nova chromosomes.

Authors:  Pawel Buczek; Rochelle S Orr; Sean R Pyper; Mili Shum; Emily Kimmel; Irene Ota; Shawn E Gerum; Martin P Horvath
Journal:  J Mol Biol       Date:  2005-07-29       Impact factor: 5.469

4.  Telomere loss in cells treated with cisplatin.

Authors:  T Ishibashi; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

5.  Relational Victimization and Telomere Length in Adolescent Girls.

Authors:  Erika M Manczak; Ian H Gotlib
Journal:  J Res Adolesc       Date:  2018-08-21

Review 6.  Joint contact stress: a reasonable surrogate for biological processes?

Authors:  Richard A Brand
Journal:  Iowa Orthop J       Date:  2005

7.  Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia.

Authors:  Marcia Bellon; Christophe Nicot
Journal:  Int J Cancer Oncol       Date:  2015-06-02

Review 8.  The Connection Between Cell Fate and Telomere.

Authors:  Ayse Basak Engin; Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.

Authors:  Yinghui Li; Qi-Ling Zhou; Wenjie Sun; Prashant Chandrasekharan; Hui Shan Cheng; Zhe Ying; Manikandan Lakshmanan; Anandhkumar Raju; Daniel G Tenen; Shi-Yuan Cheng; Kai-Hsiang Chuang; Jun Li; Shyam Prabhakar; Mengfeng Li; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2015-09-21       Impact factor: 28.824

10.  Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer.

Authors:  Jinliang Xing; Jaffer A Ajani; Meng Chen; Julie Izzo; Jie Lin; Zhinan Chen; Jian Gu; Xifeng Wu
Journal:  Cancer Prev Res (Phila)       Date:  2009-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.